Telix Pharmaceuticals Limited (TLPPF) has a market capitalization of $3.56B and trades at $10.50. The 52-week range is 5.91-19.99.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -321.1, Earnings Per Share (EPS) of $-0.03, annual revenue of $1.25B.
The stock has a beta of 0.61, operates in the Healthcare sector.
